Dramatic Tumor Response to 2nd-line Pemetrexed/Cisplatin Combination Chemotherapy in Patient with Malignant Pleural Mesothelioma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Dramatic Tumor Response to 2nd-line Pemetrexed/Cisplatin Combination Chemotherapy in Patient with Malignant Pleural Mesothelioma

Published:2007 Issue:5 Volume:62 Page:432
ISSN:1738-3536
Container-title:Tuberculosis and Respiratory Diseases
language:ko
Short-container-title:Tuberc Respir Dis

Author:

Lee Seung Min¹,Ko Soon Young¹,Seo Tae Ho¹,Lee Jung Hyun¹,Choi Seung Oh¹,Lee Jeong Geun²,Kim Wan Seop³,Lee Tae Hoon¹,Yoo Gwang Ha¹,Lee Kye Young¹

Affiliation:

1. Department of Internal Medicine, College of Medicine, Konkuk University, Seoul, Korea.

2. Department of Radiology, College of Medicine, Konkuk University, Seoul, Korea.

3. Department of Pathology, College of Medicine, Konkuk University, Seoul, Korea.

Publisher

The Korean Academy of Tuberculosis and Respiratory Diseases

Link

https://synapse.koreamed.org/pdf/10.4046/trd.2007.62.5.432

Reference21 articles.

1. The Immunohistochemical Diagnosis of Mesothelioma

2. Malignant pleural mesothelioma: a problematic review

3. Malignant pleural mesothelioma

4. Chemotherapy in malignant pleural mesothelioma. A review.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP